SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending following an updated investor presentation highlighting strategic progress, including substantial market share in Japan for its COVID-19 vaccine and the broad potential of its Matrix-M adjuvant. This news, alongside elevated short interest and fervent community discussion around a potential short squeeze, is fueling a market repricing of its protein-based vaccine platform and pipeline assets.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The Dow Jones Industrial Average is trending as it consistently pushes towards new all-time highs, fueled by broad market enthusiasm and ongoing discussions around potential Federal Reserve interest rate adjustments. While many anticipate further upside and a "Santa Claus rally," a vocal segment of the community expresses caution, pointing to stretched valuations and a divided outlook on economic conditions.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is trending following strong preliminary revenue results and a record total contract value, driven by rising demand from major pharmaceutical partners for its AI-driven data. Community discussion highlights significant volume and call flows, with traders actively debating its potential for continued growth in precision oncology amid some intraday volatility. The company's strategic partnerships and role in embedding AI into drug discovery and clinical diagnostics are frequently emphasized.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

Immediate market discussions center on the reported criminal probe into Fed Chair Powell, sparking intense debate over central bank independence and the potential for political influence on monetary policy. This uncertainty is compounded by recent U.S. action in Venezuela and proposed credit card interest rate caps, leading to polarized community views on heightened geopolitical risks and significant financial sector shifts. While the Dow Jones Industrial Average (DIA) has recently achieved new highs, its rally's sustainability is keenly debated amidst concerns over broader market fragility.

Monero

Monero ($XMR) is surging amid a renewed focus on privacy coins, with the community touting it as the "king of privacy" and the true, untraceable digital cash. Many believe XMR is outperforming competitors like Zcash and even Bitcoin due to its default privacy features, leading to widespread accumulation and ambitious long-term price targets. Despite facing delistings on major exchanges, proponents are actively discussing its fundamental utility and expressing frustration over its lack of trending visibility.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is a major topic of conversation, driven by widespread frustration over its sustained stock decline, which many investors believe contradicts the company's strong fundamentals and recent strategic AI partnerships. Community discussion is heavily focused on how a proposed credit card interest rate cap could significantly boost PayPal's Buy Now, Pay Later segment. This ongoing debate is further fueled by persistent analyst downgrades and calls for management to address the stock's underperformance.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending amid community debate over recent remarks regarding big tech's responsibility for AI data center power costs, with some anticipating increased infrastructure investment and others concerned about financial impacts. Nevertheless, analysts remain bullish on the company's robust AI and cloud monetization as a core beneficiary of the AI supercycle, despite ongoing investor frustration with its subdued price action.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as renewed geopolitical interest in Greenland's rare earth deposits, particularly CRML's Tanbreez project, drives significant community discussion. Investors are keenly watching upcoming high-level meetings between U.S., Danish, and Greenlandic officials, with many anticipating developments that could solidify CRML's strategic importance in securing critical mineral supply chains. The strong belief in Greenland's strategic value and potential short squeeze dynamics is fueling strong conviction and buying interest.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is gaining significant attention following recent company updates confirming it's fully funded for the first quarter with no planned dilution, and highlighting its molecular-level traceability technology for precious metals and anti-counterfeiting. The community is vigorously discussing its strong short squeeze potential, fueled by reports of extremely high Cost-To-Borrow rates and zero available shares, with many anticipating a substantial price surge akin to past low-float runners.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics (MLTX) is experiencing significant market attention following positive feedback from the FDA, which confirmed existing trial data is sufficient for a Biologics License Application for its drug sonelokimab in hidradenitis suppurativa, greatly de-risking its regulatory pathway. This development has fueled widespread speculation within the community about potential acquisition bids from major pharmaceutical players like Merck and Eli Lilly, with many investors anticipating a substantial revaluation and a potential short squeeze due to high interest from sellers. The discussion highlights the company's strong asset in the competitive immunology sector and its clearer path to market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Buying: Global Indemnity Group (NASDAQ:GBLI) CEO Purchases 5,000 Shares of Stock

Global Indemnity Group, LLC (NASDAQ:GBLI - Get Free Report) CEO Joseph Brown acquired 5,000 shares of the company's stock in a transaction on Tuesday, November 25th. The stock was acquired at an...

Global Indemnity Group (NASDAQ:GBLI) CEO Joseph Brown Purchases 5,000 Shares

Global Indemnity Group, LLC (NASDAQ:GBLI - Get Free Report) CEO Joseph Brown acquired 5,000 shares of Global Indemnity Group stock in a transaction dated Tuesday, November 25th. The stock was...

Global Indemnity Group, LLC Reports Third Quarter 2025 Financial Results Highlighted by 54% Growth in Current Accident Year Underwriting Income and 19% Increase in Operating Income

Global Indemnity Group, LLC (NYSE:GBLI) (the Company) today reported financial results for the three and nine months ended September 30, 2025. Third Quarter 2025 Consolidated Results and Business...

Global Indemnity Group, LLC Announces Transfer to Nasdaq Stock Exchange

Global Indemnity Group, LLC (NYSE: GBLI) (Global Indemnity or the Company) today announced that it will transfer the listing of its Class A Common Shares from the New York Stock Exchange to the...

Global Indemnity Group Q3 2025 Earnings Release & Conference Call

Global Indemnity Group, LLC (NYSE:GBLI) (GBLI), announced today that it will release its third quarter 2025 earnings before market open on Thursday, October 30, 2025. GBLI will hold an earnings call...

Global Indemnity Group LLC provides diversified insurance and reinsurance services. It operates through the Penn-America and Non-Core Operations segments. The Penn-America segment distributes specialty property and casualty insurance products in the excess and surplus lines marketplace. The Non-Core Operations segment includes manufactured and dwelling home business, farm, ranch and equine business, specialty personal lines products such as motorcycle, watercraft, and certain homeowners. The company was founded in 2003 and is headquartered in Wilmington, DE.

Global Indemnity Group LLC - Ordinary Shares - Class A

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Current Price	$28.98
Prev Close	$28.63
Open	$28.59
Dividend Yield	3.89%
50-Day Moving Average	$28.21
Beta	0.06
Avg. Volume	2,840.41
PE Ratio	15.02

52-Week High	$37.00
52-Week Low	$25.88
Market Capitalization	$446.99M
EPS (Annual)	$3.12
Price to Book	0.59
Revenue Per Employee	$1.66M
Enterprise Value/EBITDA	N/A

GBLI
Global Indemnity Group LLC - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GBLI News

GBLIGlobal Indemnity Group LLC - Ordinary Shares - Class A